2022-08-26 | NDAQ:BMRN | Press release

NEW ORLEANS, August 26, 2022 /PRNewswire/ — Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.a partner at the law firm Kahn Swick & Foti, LLC (“KSF”), announces that KSF is continuing its investigation of BioMarin Pharmaceutical Inc. (NasdaqGS: BMRN).

On August 19, 2020the company disclosed that it had received a complete response letter (“CRL”) from the FDA denying its biologics license (“BLA”) application for its product, valoctocogene roxaparvovec, and recommending two years of data from the Company’s ongoing 270-301 study (Phase 3) and that the Company “complete the Phase 3 study and submit follow-up safety and efficacy data from all two study participants years”, thus requiring a longer study before approval is considered.

Subsequently, the Company and certain of its officers were sued in a securities class action lawsuit, accusing them of failing to disclose material information during the Class Period, in violation of federal securities laws. securities. Recently, the court presiding over the case denied the company’s motion to reconsider the court’s decision partially denying the company’s motion to dismiss, thereby allowing the case to proceed.

KSF’s investigation focuses on whether BioMarin’s officers and/or directors breached their fiduciary duties to BioMarin shareholders or otherwise violated federal or state laws.

If you have information that could help KSF in its investigation, or if you have been a long-time holder of BioMarin shares and wish to discuss your legal rights, you may, at no obligation or cost to you, call toll-free 1 -877-515-1850 or email Lewis Kahn, KSF Managing Partner ([email protected]), or visit https://ksfcounsel.com/cases/biomarin-pharmaceutical-inc-nasdaqgs-bmrn/ to learn more.

About Kahn Swick & Foti, LLC

KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation’s leading securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, fund managers and retail investors – seeking to recover investment losses due to corporate fraud and malfeasance by listed companies in stock exchange. KSF has offices in New York, California, Louisiana and New Jersey.

To learn more about KSF, you can visit www.ksfcounsel.com.

Contact:

Kahn Swick & Foti, LLC

Lewis KahnManaging partner

[email protected]

1-877-515-1850

1100 Poydras Street, Suite 3200

New Orleans, LA 70163

Quote Show original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-investigation-continued-by-former-louisiana-attorney-general-kahn-swick–foti-llc-continues-to-investigate-the-officers-and -directors-of-biomarin-pharmaceutical-inc—bmrn-301613359.html

SOURCE Kahn Swick & Foti, LLC